Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2017/4817275 http://scihub22266oqcxt.onion/10.1155/2017/4817275 C5485271!5485271 !28695037     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28695037 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Case+Rep+Rheumatol 2017 ; 2017 (ä): 4817275 Nephropedia Template TP {{tp|p=28695037 |t=2017. NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation |pdf=|usr=}}{{28695037 }} gab.com Text NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation JO: Case Rep Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=28695037 #FOAvip Dermatomyositis (DM), a myopathy associated with inflammation and muscle weakness, has historically been difficult to diagnose. Recently, nuclear matrix protein (NXP-2) antibodies have been described as a myositis-specific antibody that may aid in the diagnostic evaluation. We present the case of a 21-year-old, previously healthy, African American male with DM. He presented to our outpatient clinic with periorbital swelling and a rash, for which he was started on prednisone by an ophthalmologist. Towards the end of the prednisone taper, he began to experience muscle weakness, a worsening rash, and dysphagia to solids with a resultant loss of 60 pounds within a month. He was transferred to a tertiary care hospital where he was further evaluated and ultimately diagnosed with dermatomyositis, supported by skin and muscle biopsies, and was found to be positive for NXP-2. He was given intravenous immunoglobulin (IVIG) and high-dose steroids with improvement. Twit Text FOAVip NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation ????Case Rep Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=28695037 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28695037 #FOAvip English Wikipedia <ref>{{Cite pmid|28695037 }}</ref> NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation #MMPMID28695037 Butt Z ; Patel L ; Das MK ; Mecoli CA ; Ramji A Case Rep Rheumatol 2017[]; 2017 (ä): 4817275 PMID28695037 show ga Dermatomyositis (DM), a myopathy associated with inflammation and muscle weakness, has historically been difficult to diagnose. Recently, nuclear matrix protein (NXP-2) antibodies have been described as a myositis-specific antibody that may aid in the diagnostic evaluation. We present the case of a 21-year-old, previously healthy, African American male with DM. He presented to our outpatient clinic with periorbital swelling and a rash, for which he was started on prednisone by an ophthalmologist. Towards the end of the prednisone taper, he began to experience muscle weakness, a worsening rash, and dysphagia to solids with a resultant loss of 60 pounds within a month. He was transferred to a tertiary care hospital where he was further evaluated and ultimately diagnosed with dermatomyositis, supported by skin and muscle biopsies, and was found to be positive for NXP-2. He was given intravenous immunoglobulin (IVIG) and high-dose steroids with improvement. äNXP-2 Positive Dermatomyositis: A Unique Clinical Presentation (epmc).pdf DeepDyve Pubget Overpricing